ustransplant.org -- Transplant Statistics Reference Tables

Transplant Statistics: Annual Report : Reference Tables

Table 9.6d

Immunosuppression Use: Antirejection Treatment from Transplant

to One Year Post Transplant, 1991 to 2000

Recipients with Liver Transplants

		Year of Transplant
		1991	1992	1993	1994	1995	1996	1997	1998	1999	2000
Transplants		2,954	3,064	3,440	3,652	3,931	4,077	4,185	4,503	4,715	4,962
Tx with Antirejection Treatments		1,476	1,440	1,692	1,540	1,310	1,242	1,272	1,136	1,393	1,435
Antibodies	Category Usage	31.0%	33.0%	35.2%	30.1%	22.0%	13.8%	12.4%	12.2%	11.7%	14.6%
	ALG	0.0%	0.1%	0.7%	1.4%	0.9%	0.0%	0.0%	0.0%	0.0%	0.0%
	ATG	0.1%	0.6%	2.7%	2.4%	1.2%	1.9%	1.4%	1.2%	0.6%	0.5%
	NRATG/NRATS	0.0%	0.0%	0.0%	0.1%	0.0%	0.1%	0.1%	0.1%	0.1%	0.0%
	OKT3	31.0%	32.7%	33.3%	27.7%	20.7%	12.5%	11.4%	9.7%	6.7%	6.2%
	Thymoglobulin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.4%	1.6%	3.1%
	Zenapax	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.2%	0.7%	1.9%	2.5%
	Simulect	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.1%	0.6%	2.2%	3.2%
Corticosteroids	Category Usage	90.8%	91.8%	86.8%	85.3%	83.0%	83.1%	82.9%	86.7%	89.0%	89.7%
	Prednisone	58.1%	61.5%	57.2%	29.5%	18.5%	17.1%	17.0%	24.9%	35.8%	34.3%
	Methylprednisolone	44.6%	42.4%	46.1%	71.2%	75.0%	75.0%	75.5%	73.2%	68.3%	68.9%

Source: OPTN/SRTR Data as of August 1, 2002.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

SRTR Site designed and maintained by Diamond Bullet Design & URREA.